Bank Of America Corp Surface Oncology, Inc. Transaction History

Bank Of America Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.57 - $0.88 $624 - $963	-1,095 Reduced 2.78%	38,321 $33,000
Q1 2023 May 12, 2023	BUY	$0.61 - $1.03 $9,128 - $15,413	14,965 Added 61.2%	39,416 $27,000
Q4 2022 Feb 10, 2023	SELL	$0.62 - $1.21 $24,412 - $47,643	-39,375 Reduced 61.69%	24,451 $20,000
Q3 2022 Nov 14, 2022	BUY	$1.05 - $2.1 $24,995 - $49,990	23,805 Added 59.48%	63,826 $66,000
Q2 2022 Aug 12, 2022	BUY	$1.42 - $3.15 $32,177 - $71,379	22,660 Added 130.52%	40,021 $65,000
Q1 2022 May 16, 2022	SELL	$2.65 - $5.08 $216,335 - $414,710	-81,636 Reduced 82.46%	17,361 $51,000
Q4 2021 Feb 08, 2022	BUY	$4.73 - $7.9 $337,234 - $563,246	71,297 Added 257.39%	98,997 $474,000
Q3 2021 Nov 15, 2021	BUY	$5.16 - $7.98 $53,638 - $82,952	10,395 Added 60.07%	27,700 $210,000
Q2 2021 Sep 13, 2021	BUY	$6.45 - $9.09 $111,617 - $157,302	17,305 New	17,305 $129,000

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.